New Multi-Organ-Chip project towards vaccine & drug candidate testing for Tuberculosis

TissUse will receive funding from the Bill & Melinda Gates Foundation to develop a human preclinical lung-liver-lymph node co-culture on a HUMIMIC Chip infectable with Mycobacterium tuberculosis. This collaboration will […]

Weiterlesen

Philip Morris International and TissUse develop a human aerosol test platform to emulate the entire human respiratory tract

PMI and TissUse have signed a collaboration agreement to utilize PMI’s InHALES technology in combination with TissUse’s proprietary Multi-Organ-Chip (MOC) platform to enable inhalation exposure of functional human tissues in […]

Weiterlesen

TissUse launcht neue Produktmarkte HUMIMIC

TissUse, die Berliner Pioniere in Human-on-a-Chip Entwicklungen haben Ihre Produktmarke HUMIMIC gelauncht. Unter diesem Brand werden in Zukunft alle Produkte des Unternehmens gebündelt. Unter der Marke HUMIMIC bekommen die Produkte […]

Weiterlesen